352 related articles for article (PubMed ID: 15007594)
1. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
Parrott AC
Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
Tanner-Smith EE
Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
[TBL] [Abstract][Full Text] [Related]
3. Content of ecstasy in the Netherlands: 1993-2008.
Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
[TBL] [Abstract][Full Text] [Related]
4. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
5. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
[TBL] [Abstract][Full Text] [Related]
6. An exploration of the history and controversies surrounding MDMA and MDA.
Pentney AR
J Psychoactive Drugs; 2001; 33(3):213-21. PubMed ID: 11718314
[TBL] [Abstract][Full Text] [Related]
7. The variability of ecstasy tablets composition in Brazil.
Togni LR; Lanaro R; Resende RR; Costa JL
J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
[TBL] [Abstract][Full Text] [Related]
8. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
van der Gouwe D; Brunt TM; van Laar M; van der Pol P
Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
[TBL] [Abstract][Full Text] [Related]
9. mCPP: an undesired addition to the ecstasy market.
Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
[TBL] [Abstract][Full Text] [Related]
10. Multiple drug ingestion by ecstasy abusers in the United States.
Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
J Anal Toxicol; 2009 Apr; 33(3):143-7. PubMed ID: 19371462
[TBL] [Abstract][Full Text] [Related]
11. Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?
Vidal Giné C; Ventura Vilamala M; Fornís Espinosa I; Gil Lladanosa C; Calzada Álvarez N; Fitó Fruitós A; Rodríguez Rodríguez J; Domíngo Salvany A; de la Torre Fornell R
Forensic Sci Int; 2016 Jun; 263():164-168. PubMed ID: 27129144
[TBL] [Abstract][Full Text] [Related]
12. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
13. The History of MDMA as an Underground Drug in the United States, 1960-1979.
Passie T; Benzenhöfer U
J Psychoactive Drugs; 2016; 48(2):67-75. PubMed ID: 26940772
[TBL] [Abstract][Full Text] [Related]
14. The content of ecstasy tablets: implications for the study of their long-term effects.
Cole JC; Bailey M; Sumnall HR; Wagstaff GF; King LA
Addiction; 2002 Dec; 97(12):1531-6. PubMed ID: 12472637
[TBL] [Abstract][Full Text] [Related]
15. Supported liquid-liquid extraction of the active ingredient (3,4-methylenedioxymethylamphetamine) from ecstasy tablets for isotopic analysis.
de Korompay A; Hill JC; Carter JF; NicDaeid N; Sleeman R
J Chromatogr A; 2008 Jan; 1178(1-2):1-8. PubMed ID: 18070626
[TBL] [Abstract][Full Text] [Related]
16. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
[TBL] [Abstract][Full Text] [Related]
17. Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).
Schifano F; Corkery J; Deluca P; Oyefeso A; Ghodse AH
J Psychopharmacol; 2006 May; 20(3):456-63. PubMed ID: 16574720
[TBL] [Abstract][Full Text] [Related]
18. The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).
Freudenmann RW; Spitzer M
CNS Drug Rev; 2004; 10(2):89-116. PubMed ID: 15179441
[TBL] [Abstract][Full Text] [Related]
19. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
Brunt TM; Koeter MW; Niesink RJ; van den Brink W
Psychopharmacology (Berl); 2012 Apr; 220(4):751-62. PubMed ID: 21993879
[TBL] [Abstract][Full Text] [Related]
20. A turn-on fluorogenic probe for detection of MDMA from ecstasy tablets.
Moreno D; Díaz de Greñu B; García B; Ibeas S; Torroba T
Chem Commun (Camb); 2012 Mar; 48(24):2994-6. PubMed ID: 22314849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
